Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Disc Medicine Inc shares valued at $116,458 were purchased by JEAN FRANCHI on Jul 17 ’25. At $57.34 per share, JEAN FRANCHI acquired 2,031 shares.
Also, Franchi Jean M. sold 2,000 shares, netting a total of over 115,000 in proceeds. Following the sale of shares at $57.50 each, the insider now holds 65,530 shares.
Before that, Quisel John D had sold 34,800 shares from its account. In a trade valued at $1,925,525, the Chief Executive Officer traded Disc Medicine Inc shares for $55.33 each. Upon closing the transaction, the insider’s holdings decreased to 34,800 shares, worth approximately $9.35 million.
As of February 27, 2025, TD Cowen has initiated its “Buy” rating for IRON. Earlier on November 05, 2024, Morgan Stanley upgraded its rating. Their new recommendation was “an Overweight” for IRON stock which previously was a “an Equal-weight”.
Analyzing IRON Stock Performance
On last trading session,, Disc Medicine Inc [NASDAQ: IRON] rose 0.78% to $57.79. The stock’s lowest price that day was $57.42, but it reached a high of $59.715 in the same session. During the last five days, there has been a drop of approximately -0.36%. Over the course of the year, Disc Medicine Inc shares have jumped approximately 17.39%.
Support And Resistance Levels for Disc Medicine Inc (IRON)
RSI (Relative Strength Index) is 61.80 on the 14-day chart, showing neutral technical sentiment.
Is Disc Medicine Inc subject to short interest?
Stocks of Disc Medicine Inc saw a sharp steep in short interest on 2025-06-13 dropping by 26633.0 shares to 3.2 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 3.23 million shares. A decline of -0.83% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 8.99 of the overall float, the days-to-cover ratio (short ratio) decline to 8.99.
Which companies own the most shares of Disc Medicine Inc (IRON)?
In terms of Disc Medicine Inc share price expectations, FactSet research, analysts set an average price target of 70.5 in the next 12 months, up nearly 22.95% from the previous closing price of $57.34. Analysts anticipate Disc Medicine Inc stock to reach 112 by 2025, with the lowest price target being 43. In spite of this, 9 analysts ranked Disc Medicine Inc stock as Buy at the end of 2025. On November 04, 2024, Raymond James assigned a price target of “a Strong buy” to the stock and upgraded coverage with a $110.
